Stockscreener 앱 받기
76.72
0.21%
0.16
시간 외 거래:
76.72
전일 마감가:
$76.56
열려 있는:
$77.85
하루 거래량:
2.99M
Relative Volume:
0.70
시가총액:
$45.04B
수익:
$5.69B
순이익/손실:
$1.41B
주가수익비율:
10.99
EPS:
6.9828
순현금흐름:
$577.90M
1주 성능:
-1.35%
1개월 성능:
-5.21%
6개월 성능:
+11.19%
1년 성능:
+18.87%
1일 변동 폭
$76.54
$78.04
1주일 범위
$73.90
$78.37
52주 변동 폭
$64.51
$83.00
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
EW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
76.72 | 44.95B | 5.69B | 1.41B | 577.90M | 6.9828 |
|
ABT
Abbott Laboratories
|
133.02 | 232.77B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.90 | 143.29B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.24 | 140.03B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
98.33 | 126.25B | 34.20B | 4.69B | 5.30B | 3.6218 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
| 2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition - Investing.com
Evercore ISI Upgrades Edwards Lifesciences to Outperform From In Line, Adjusts PT to $88 From $80 - MarketScreener
Here's What to Expect From Edwards Lifesciences’ Next Earnings Report - MSN
Here's What To Expect From Edwards Lifesciences’ Next Earnings Report - Barchart.com
EW Investor News: If You Have Suffered Losses in Edwards - GlobeNewswire
EW 投資者消息：若您因 Edwards Lifesciences Corporation (NYSE: EW) 蒙受損失，請聯絡 Rosen Law Firm 了解您的權益 - GlobeNewswire Inc.
What high frequency data says about Edwards Lifesciences CorporationJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Park Avenue Securities LLC Makes New Investment in Edwards Lifesciences Corporation $EW - Defense World
Real time alert setup for Edwards Lifesciences Corporation performance2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences CorporationEW - MarketScreener
One Wealth Advisors LLC Sells 9,296 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Will Edwards Lifesciences Corporation stock return to pre crisis levelsRate Hike & Risk Managed Investment Entry Signals - newser.com
Is It Time To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)? - Yahoo Finance
Edwards Lifesciences Corporation $EW Shares Sold by Capital Insight Partners LLC - MarketBeat
TD Private Client Wealth LLC Invests $169,000 in Edwards Lifesciences Corporation $EW - Defense World
Wall Street Zen Downgrades Edwards Lifesciences (NYSE:EW) to Buy - MarketBeat
Edwards Lifesciences Corporation EWL Stock Analysis and ForecastRSI Overbought/Oversold & Get Tomorrow’s Winners Today With AI - earlytimes.in
What drives Edwards Lifesciences Corporation EWL stock pricePortfolio Risk Assessment & Fast Profit Trading Ideas - earlytimes.in
Banque Pictet & Cie SA Trims Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Bank Pictet & Cie Europe AG Purchases 15,004 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW - Business Wire
CHICAGO TRUST Co NA Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Swedbank AB - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by BDF Gestion - MarketBeat
Diversified Trust Co Buys 4,454 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
MassMutual Private Wealth & Trust FSB Decreases Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
The Returns On Capital At Edwards Lifesciences (NYSE:EW) Don't Inspire Confidence - Yahoo Finance
Stifel Lowers Price Target for Edwards Lifesciences (EW) to $85 - GuruFocus
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $95, Maintains Buy Rating - MarketScreener
Edwards Lifesciences price target lowered to $85 by Stifel on TAVR data concerns - Investing.com
NorthCrest Asset Manangement LLC Takes $330,000 Position in Edwards Lifesciences Corporation $EW - MarketBeat
Wealth Enhancement Advisory Services LLC Buys 86,186 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Czech National Bank - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Sees Significant Increase in Short Interest - MarketBeat
Performance Recap: Does Energy Fuels Inc. stock reflect fundamentalsJuly 2025 Institutional & Community Verified Watchlist Alerts - khodrobank.com
Aug PreEarnings: How sensitive is Edwards Lifesciences Corporation to inflation2025 Market Outlook & Weekly Stock Breakout Alerts - خودرو بانک
Edwards Lifesciences Corporation $EW Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Aug Movers: Whats the outlook for Edwards Lifesciences Corporations sectorEntry Point & Growth Oriented Trade Recommendations - khodrobank.com
E. Ohman J or Asset Management AB Acquires New Shares in Edwards Lifesciences Corporation $EW - MarketBeat
Seilern Investment Management Ltd Has $96.89 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (EW): A Bull Case Theory - Yahoo Finance
Capital Asset Advisory Services LLC Acquires Shares of 5,853 Edwards Lifesciences Corporation $EW - MarketBeat
Neville Rodie & Shaw Inc. Sells 3,522 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Treasury Yields: Will Edwards Lifesciences Corporation outperform its industry peersLong Setup & Fast Moving Trade Plans - خودرو بانک
Analysis Recap: Whats the outlook for Edwards Lifesciences Corporations sectorGold Moves & Real-Time Volume Triggers - khodrobank.com
Aug Rallies: What makes WLDSW stock attractive today2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - khodrobank.com
Swedbank AB Decreases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
0.38%
자본화:
|
볼륨(24시간):